Not recruiting
Cerebral palsy+1
Not recruitingRegistered drug
Study on the Effectiveness and Safety of NT 201 for Treating Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy
Registered drug
- Disease:Cerebral palsyMuscle spasticity
- Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Countries:
Poland
Poland- Participants:0–17 years
- Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
- Sponsor:Merz Pharmaceuticals GmbH

